Shufro Rose & CO LLC Bristol Myers Squibb CO Transaction History

Shufro Rose & CO LLC

$1.27 Billion
Q3 2024

A detailed history of Shufro Rose & CO LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Shufro Rose & CO LLC holds 9,010 shares of BMY stock, worth $509,695. This represents 0.04% of its overall portfolio holdings.

Number of Shares

9,010

Previous 9,010 -0.0%

Holding current value

$509,695

Previous $374,000 24.6%

% of portfolio

0.04%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $10,062 - $13,247	250 Added 2.85%	9,010 $374,000
Q1 2023 Apr 19, 2023	SELL	$65.71 - $74.53 $89,102 - $101,062	-1,356 Reduced 13.4%	8,760 $607,000
Q4 2022 Jan 25, 2023	BUY	$68.48 - $81.09 $37,800 - $44,761	552 Added 5.77%	10,116 $0
Q3 2022 Oct 24, 2022	BUY	$0.13 - $76.84 $95 - $56,707	738 Added 8.36%	9,564 $680,000
Q2 2022 Jul 22, 2022	BUY	$72.62 - $79.98 $2,469 - $2,719	34 Added 0.39%	8,826 $680,000
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $5,533 - $6,634	-90 Reduced 1.01%	8,792 $642,000
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $173,190 - $202,870	-2,927 Reduced 24.79%	8,882 $526,000
Q2 2021 Jul 28, 2021	SELL	$61.91 - $67.42 $25.8 Million - $28.1 Million	-417,184 Reduced 97.25%	11,809 $789,000
Q1 2021 Apr 28, 2021	SELL	$59.34 - $66.74 $803,166 - $903,325	-13,535 Reduced 3.06%	428,993 $27.1 Million
Q4 2020 Feb 03, 2021	SELL	$57.74 - $65.43 $294,069 - $333,234	-5,093 Reduced 1.14%	442,528 $27.5 Million
Q3 2020 Oct 27, 2020	SELL	$57.43 - $63.64 $44,508 - $49,321	-775 Reduced 0.17%	447,621 $27 Million
Q2 2020 Aug 06, 2020	SELL	$54.82 - $64.09 $166,762 - $194,961	-3,042 Reduced 0.67%	448,396 $26.4 Million
Q1 2020 Apr 22, 2020	SELL	$46.4 - $67.43 $378,160 - $549,554	-8,150 Reduced 1.77%	451,438 $25.2 Million
Q4 2019 Jan 28, 2020	SELL	$49.21 - $64.19 $360,807 - $470,641	-7,332 Reduced 1.57%	459,588 $29.5 Million
Q3 2019 Oct 30, 2019	SELL	$42.77 - $50.71 $76,558 - $90,770	-1,790 Reduced 0.38%	466,920 $23.7 Million
Q2 2019 Jul 24, 2019	SELL	$44.62 - $49.34 $194,320 - $214,875	-4,355 Reduced 0.92%	468,710 $21.3 Million
Q1 2019 May 03, 2019	SELL	$45.12 - $53.8 $5.25 Million - $6.25 Million	-116,262 Reduced 19.73%	473,065 $22.6 Million
Q4 2018 Feb 01, 2019	SELL	$48.76 - $63.23 $385,837 - $500,338	-7,913 Reduced 1.32%	589,327 $30.6 Million
Q3 2018 Oct 26, 2018	BUY	$55.19 - $62.25 $53,589 - $60,444	971 Added 0.16%	597,240 $37.1 Million
Q2 2018 Jul 27, 2018	BUY	$50.53 - $62.98 $743,548 - $926,750	14,715 Added 2.53%	596,269 $33 Million
Q1 2018 May 04, 2018	SELL	$59.92 - $68.98 $215,652 - $248,259	-3,599 Reduced 0.62%	581,554 $36.8 Million
Q4 2017 Feb 06, 2018	SELL	$59.94 - $65.35 $164,055 - $178,862	-2,737 Reduced 0.47%	585,153 $35.9 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $32.5 Million - $37.5 Million	587,890	587,890 $37.5 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shufro Rose & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shufro Rose & CO LLC with notifications on news.

Account

Shufro Rose & CO LLC Bristol Myers Squibb CO Transaction History